高级检索

血清成纤维细胞生长因子23、S100A12对老年糖尿病患者动脉粥样硬化性心血管病的预测价值

Prognostic value of serum fibroblast growth factor 23 and S100A12 for atherosclerosis cardiovascular disease in elderly patients with diabetes

    摘要
  • 摘要:
    目的 探讨血清成纤维细胞生长因子23(FGF23)、S100A12对老年糖尿病患者动脉粥样硬化性心血管病(ASCVD)的预测价值。
    方法 选取133例老年糖尿病患者为研究对象，根据是否合并ASCVD，将其分为糖尿病组(n=59)和ASCVD组(n=74)。选取同期行体检的健康者为对照组(n=56)。检测并比较血清FGF23、S100A12表达水平。采用多因素Logistic回归分析法分析老年糖尿病患者发生ASCVD的影响因素。评估血清FGF23、S100A12水平对ASCVD发生的预测价值。
    结果 ASCVD组高血压比例、空腹血糖、糖尿病病程高于或长于糖尿病组，差异有统计学意义(P < 0.05)。ASCVD组血清FGF23、S100A12表达水平高于糖尿病组、对照组，差异有统计学意义(P < 0.05)。高血压、血清FGF23、S100A12表达水平是影响老年糖尿病患者发生ASCVD的独立影响因素(P < 0.05)。血清FGF23、S100A12单独预测老年糖尿病患者发生ASCVD的曲线下面积(AUC)分别为0.755、0.874, 二者联合预测的AUC为0.934, 灵敏度和特异度分别为82.43%、89.83%。血清FGF23、S100A12联合预测优于其单独预测(P < 0.05)。
    结论 老年糖尿病患者的血清FGF23、S100A12水平均升高。血清FGF23、S100A12联合预测老年糖尿病患者发生ASCVD的价值相较单独预测更高。

     

    Abstract:
    Objective To investigate the predictive value of serum fibroblast growth factor 23 (FGF23) and S100A12 for atherosclerosis cardiovascular disease (ASCVD) in elderly patients with diabetes.
    Methods A total of 133 elderly patients with diabetes were selected as the study subjects and divided into diabetes group (n=59) and ASCVD group (n=74) according to whether they had ASCVD or not. Healthy subjects who underwent physical examination at the same time were selected as the control group (n=56). The expression levels of serum FGF23 and S100A12 were detected and compared. Multivariate Logistic regression analysis was used to analyze the influencing factors of ASCVD in elderly diabetic patients. The predictive value of serum FGF23 and S100A12 levels for the occurrence of ASCVD was evaluated.
    Results The proportion of hypertension, fasting blood glucose and diabetes course in the ASCVD group were significantly higher or longer than those in the diabetes group (P < 0.05). The expression levels of serum FGF23 and S100A12 in the ASCVD group were significantly higher than those in the diabetes group and control group (P < 0.05). The expression levels of hypertension, serum FGF23 and S100A12 were the independent influencing factors for ASCVD in elderly patients with diabetes (P < 0.05). The area under the curve (AUC) of serum FGF23 and S100A12 to predict ASCVD in elderly diabetic patients were 0.755 and 0.874, respectively, and the AUC of serum FGF23 and S100A12 combined to predict ASCVD was 0.934, and the sensitivity and specificity were 82.43% and 89.83%, respectively. The combined prediction of serum FGF23 and S100A12 was better than the single prediction (P < 0.05).
    Conclusion Serum levels of FGF23 and S100A12 are increased in elderly patients with diabetes. The combination of serum FGF23 and S100A12 has a higher value in predicting ASCVD in elderly diabetic patients compared to their lonely detection.

     

    • HTML全文
    • 参考文献(23)
    • 相关文章
    • 施引文献
  • 资源附件(0)

/

返回文章
返回